StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.78+0.02 (+2.36%)

Close on Nov 18, 2026Market cap $35.02MP/E –Yield –

TELA Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

TELA Bio's price to book ratio was 6.2× on Apr 30, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 1.3× to 62.0×, with a median of 6.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20266.2×−24.4
2025Dec 31, 202530.6×+6.4
2024Oct 31, 202424.2×+18.9
2023Dec 29, 20235.3×−4.1
2022Dec 30, 20229.5×+2.8
2021Dec 31, 20216.7×+2.8
2020Dec 31, 20203.9×–

More TELA Bio figures

See a number that looks wrong?